Your session is about to expire
← Back to Search
AFDST with BPA for Atrial Fibrillation
Study Summary
This trial is designed to improve thromboprophylaxis treatment decisions for patients with non-valvular AF and to increase awareness of the underutilization of appropriate thromboprophylaxis in the University of Cincinnati Health system.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any current opportunities to join this research experiment?
"Indeed, the information on clinicaltrials.gov shows that this research project is actively enrolling participants. It was posted to the website on November 18th 2020 and has been updated most recently in February 8th 2022 - with a need for 144 patients at one location being specified."
What is the scope of enrollment for this trial?
"Affirmative. According to the data on clinicaltrials.gov, this medical investigation is presently recruiting volunteers. This trial was published on November 18th 2020 and last updated February 8th 2022 with a goal of enrolling 144 subjects in one location."
Share this study with friends
Copy Link
Messenger